Meniscus Injury

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

FUJIFILM Pharma
FUJIFILM PharmaMA - Cambridge
1 program
1
human autologous synovial stem cellsPhase 31 trial
Active Trials
NCT05777967UnknownEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
FUJIFILM Pharmahuman autologous synovial stem cells

Clinical Trials (1)

NCT05777967FUJIFILM Pharmahuman autologous synovial stem cells

Efficacy and Safety of FF-31501 in Meniscus Tear Patients

Start: Jan 2023Est. completion: Dec 2025
Phase 3Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space